Sens. Bill Cassidy (R-LA), Michael Bennet (D-CO), Chuck Grassley (R-IA), Tom Carper (D-DE), Todd Young (R-IN) and Claire McCaskill (D-MO) are seeking guidance from health care stakeholders as they develop legislation to improve price transparency in the health care market and lower costs. In a letter yesterday to health care, patient and business groups, including the AHA, the senators request feedback by March 23 on questions ranging from what consumer price and quality information is or should be available, who should be responsible for providing and sharing price information, and how to avoid creating unnecessary or additional burdens. The senators plan to host roundtable conversations with a variety of experts in the coming weeks, and are also engaging the administration, members of Congress and governors. AHA plans to submit comments.

Related News Articles

Headline
A KFF survey published today found that people view prior authorization as the biggest challenge beyond costs when navigating the health care system. In terms…
Headline
The Department of Labor has issued a proposed rule to improve transparency of fees collected by pharmacy benefit managers. The rule requires PBMs to disclose…
Headline
The Department of Health and Human Services Office of Inspector General Jan. 27 released a bulletin addressing how direct-to-consumer drug programs can sell…
Headline
The Centers for Medicare & Medicaid Services Jan. 27 announced 15 drugs under Medicare Parts D and B selected for the third round of price negotiations.…
Headline
A KFF analysis released Jan. 28 found that Medicare Advantage insurers made nearly 53 million prior authorization determinations in 2024, an increase…
Headline
The AHA Jan. 26 released a white paper on addressing challenges in implementing an advanced explanation of benefits, which requires coordination among multiple…